TIDMINHC
RNS Number : 9023N
Induction Healthcare Group PLC
07 June 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Directorate Change
Appointment of new Chairman
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that
Christopher Samler has been appointed as Non-Executive Chairman.
Christopher takes over from Chris Spencer, with immediate effect,
after an externally facilitated recruitment process.
Christopher has held a number of roles as Chief Executive
Officer and Chair of quoted companies (both Main Market and AIM)
and private businesses in the education, healthcare, services and
technology sectors. He also has significant experience supporting
growth for businesses across the U.S. and Europe, as well as
emerging economies in Asia, Latin America and the Middle East.
Christopher started his career in the British Army before
joining The Boston Consulting Group as an analyst which led to a
variety of senior general management positions at Baxter
International, the US-based healthcare multinational. Subsequently,
Christopher was Chief Executive Officer of a series of fast-growing
venture capital backed healthcare businesses including Imutran Ltd
and Weston Medical plc, the latter of which he took through three
venture capital funding rounds to an IPO on the Main Market of the
London Stock Exchange in 2000.
In 2004, Christopher co-founded Iceni Capital LLP, a successful
private equity / venture capital firm focused on providing capital
and operational support to fast growing UK companies in the
services sector. More recently, he has chaired a number of high
growth technology, healthcare and service companies including TQ
Education & Training, AirPortr, Sphonic Solutions, Bubble and
Tristel plc.
Christopher holds an MA (hons) from the University of Oxford and
an MBA from the Harvard Business School.
Chris Spencer is leaving, following the completion of his three
year term, to pursue non-commercial projects and spend more time
with his family.
Chris Spencer, former Chair said : "Having chaired the Board
since the Company's IPO, I am pleased to be departing at a time
when Induction has strongly ended the financial year to 31 March
2022, announced substantial contract renewals, and successfully
begun a period of transition into a growth phase."
Induction CEO, James Balmain, said: "I am thrilled to welcome
Christopher to the Board of Induction and look forward to working
alongside him. Christopher has a wealth of directly relevant
expertise that will be invaluable as we drive the business through
this next phase of growth.
"I would like to genuinely thank Chris Spencer for the great
contribution he's made to Induction and the support he's given me
personally as a first time public markets CEO. Chris leaves
Induction in a strong position, with solid foundations and a very
bright future. I wish him the very best for the future."
Disclosures in accordance with the AIM Rules
Mr. Christopher Hadley Samler, 64, is, or has been, a director
or partner of the following companies or partnerships during the
past five years:
Current directorships and partnerships:
Cwm Cloch MJC Hydro Ltd
Airportr Technologies Limited
Tribo Technologies Limited
Nant Hir Hydro Scheme Limited
Maes Elwy Hydro Limited
Previous directorships and partnerships held in the past five
years:
Creeton with Counthorpe Broadband Community Interest Company
(dissolved)
Symphonic Solutions Limited
Future Digital Footprint Limited
La Salle Education Limited
Laundrapp Limited
Mr. Samler owns no shares in Induction.
There are no further disclosures required in accordance with AIM
Rule 17 and Schedule Two paragraph (g) of the AIM Rules for
Companies.
- ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd +44 (0)20 7933 8780 or induction@walbrookpr.com
Alice Woodings / Paul McManus Mob: +44 (0)7407 804 654 / +44
(0)7980 541 893
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access . Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAUPURCQUPPGQQ
(END) Dow Jones Newswires
June 07, 2022 02:01 ET (06:01 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024
